214 related articles for article (PubMed ID: 29402700)
1. Chromatin organisation and cancer prognosis: a pan-cancer study.
Kleppe A; Albregtsen F; Vlatkovic L; Pradhan M; Nielsen B; Hveem TS; Askautrud HA; Kristensen GB; Nesbakken A; Trovik J; Wæhre H; Tomlinson I; Shepherd NA; Novelli M; Kerr DJ; Danielsen HE
Lancet Oncol; 2018 Mar; 19(3):356-369. PubMed ID: 29402700
[TBL] [Abstract][Full Text] [Related]
2. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Domingo E; Camps C; Kaisaki PJ; Parsons MJ; Mouradov D; Pentony MM; Makino S; Palmieri M; Ward RL; Hawkins NJ; Gibbs P; Askautrud H; Oukrif D; Wang H; Wood J; Tomlinson E; Bark Y; Kaur K; Johnstone EC; Palles C; Church DN; Novelli M; Danielsen HE; Sherlock J; Kerr D; Kerr R; Sieber O; Taylor JC; Tomlinson I
Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):635-643. PubMed ID: 30042065
[TBL] [Abstract][Full Text] [Related]
3. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
[TBL] [Abstract][Full Text] [Related]
4. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.
Skrede OJ; De Raedt S; Kleppe A; Hveem TS; Liestøl K; Maddison J; Askautrud HA; Pradhan M; Nesheim JA; Albregtsen F; Farstad IN; Domingo E; Church DN; Nesbakken A; Shepherd NA; Tomlinson I; Kerr R; Novelli M; Kerr DJ; Danielsen HE
Lancet; 2020 Feb; 395(10221):350-360. PubMed ID: 32007170
[TBL] [Abstract][Full Text] [Related]
5. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
6. Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers.
Nielsen B; Kleppe A; Hveem TS; Pradhan M; Syvertsen RA; Nesheim JA; Kristensen GB; Trovik J; Kerr DJ; Albregtsen F; Danielsen HE
J Natl Cancer Inst; 2018 Dec; 110(12):1400-1408. PubMed ID: 29684152
[TBL] [Abstract][Full Text] [Related]
7. A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
Kleppe A; Skrede OJ; De Raedt S; Hveem TS; Askautrud HA; Jacobsen JE; Church DN; Nesbakken A; Shepherd NA; Novelli M; Kerr R; Liestøl K; Kerr DJ; Danielsen HE
Lancet Oncol; 2022 Sep; 23(9):1221-1232. PubMed ID: 35964620
[TBL] [Abstract][Full Text] [Related]
8. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
10. Prognostic markers for colorectal cancer: estimating ploidy and stroma.
Danielsen HE; Hveem TS; Domingo E; Pradhan M; Kleppe A; Syvertsen RA; Kostolomov I; Nesheim JA; Askautrud HA; Nesbakken A; Lothe RA; Svindland A; Shepherd N; Novelli M; Johnstone E; Tomlinson I; Kerr R; Kerr DJ
Ann Oncol; 2018 Mar; 29(3):616-623. PubMed ID: 29293881
[TBL] [Abstract][Full Text] [Related]
11. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
12. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
Yamashita R; Long J; Longacre T; Peng L; Berry G; Martin B; Higgins J; Rubin DL; Shen J
Lancet Oncol; 2021 Jan; 22(1):132-141. PubMed ID: 33387492
[TBL] [Abstract][Full Text] [Related]
13. CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma.
Slik K; Turkki R; Carpén O; Kurki S; Korkeila E; Sundström J; Pellinen T
Am J Surg Pathol; 2019 Nov; 43(11):1473-1482. PubMed ID: 31490234
[TBL] [Abstract][Full Text] [Related]
14. Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy.
Dunne PD; McArt DG; O'Reilly PG; Coleman HG; Allen WL; Loughrey M; Van Schaeybroeck S; McDade S; Salto-Tellez M; Longley DB; Lawler M; Johnston PG
Cancer Immunol Res; 2016 Jul; 4(7):582-91. PubMed ID: 27197062
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
16. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
[No Abstract] [Full Text] [Related]
19. Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer.
Yang L; Chen P; Zhang L; Wang L; Sun T; Zhou L; Li Z; Wu A
Br J Cancer; 2020 Sep; 123(6):973-981. PubMed ID: 32624576
[TBL] [Abstract][Full Text] [Related]
20. Chromatin changes predict recurrence after radical prostatectomy.
Hveem TS; Kleppe A; Vlatkovic L; Ersvær E; Wæhre H; Nielsen B; Kjær MA; Pradhan M; Syvertsen RA; Nesheim JA; Liestøl K; Albregtsen F; Danielsen HE
Br J Cancer; 2016 May; 114(11):1243-50. PubMed ID: 27124335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]